Literature DB >> 21189848

Study of the effect of oral gabapentin used as preemptive analgesia to attenuate post-operative pain in patients undergoing abdominal surgery under general anesthesia.

Harshel G Parikh1, Sananta Kumar Dash, Chitra B Upasani.   

Abstract

AIMS: To study the effect of oral gabapentin used as preemptive analgesia to attenuate post operative pain in patients undergoing abdominal surgery under general anesthesia.
MATERIALS AND METHODS: In a randomized double blind study, 60 patients were divided into two groups. Group A received 600mg gabapentin and group B oral received placebo 1 h prior to surgery. Anesthesia was induced with Propofol 2 mg/kg and Vecuronium 0.1mg/kg and maintained with 60% N(2)O in O(2) and Vecuronium 0.02 mg/kg. All cases were given Fentanyl 2µg/kg as pre medication and a repeat dose 1µg/kg at the end of the first hour. Assessment of post-operative pain was made with the visual analog score (VAS) at extubation (0 h), 2, 4, 6, 12, and 24 h post-operatively. Post-operative analgesia was provided with intravenous Tramadol. The first dose was given in the Post Anesthesia Care Unit as 2mg/kg, and repeated at 8 and 16 h. Rescue analgesia was given with Diclofenac 1.5mg/kg, slow intravenous. The number of doses of rescue analgesia in both the groups was noted.
RESULTS: The VAS scores at 0, 2, 4, 6, 12, and 24 h were 1.9 vs. 2.4 (P=0.002), 2.3 vs. 3.0 (P=0.000), 3.2 vs. 3.7 (P=0.006), 2.9 vs. 4.4 (P=0.000), 3.6 vs. 4.6 (P=0.000), and 3.7 vs.4.6 (P=0.000), respectively. Numbers of patients requiring rescue analgesia with Diclofenac were 3 vs. 14 (P=0.004).
CONCLUSION: A single oral dose of gabapentin given pre-operatively enhanced the analgesic effect of Tramadol as it also reduced the requirement of rescue analgesia with Diclofenac.

Entities:  

Keywords:  Abdominal surgery; gabapentin; post-operative pain; pre-emptive analgesia

Year:  2010        PMID: 21189848      PMCID: PMC2980657          DOI: 10.4103/1658-354X.71409

Source DB:  PubMed          Journal:  Saudi J Anaesth


INTRODUCTION

Post-operative pain is not purely nociceptive in nature and may consist of inflammatory, neurogenic, and visceral components. Therefore, multimodal analgesic techniques utilizing a number of drugs acting on different analgesic mechanisms are becoming increasingly popular.[1] Post-operative pain affects recovery from surgery and anesthesia. The use of opioids by patient-controlled analgesia is popular, but limited by side-effects and by the fact that certain types of pain respond poorly to opioids.[2] Because of the multiplicity of the mechanisms involved in post-operative pain, a multimodal analgesia regimen with a combination of opioid and non-opioid analgesic drugs is often used to enhance analgesic efficacy and reduce opioid requirements and side-effects.[3] Gabapentin, a structural analog of gamma aminobutyric acid, is used as an anticonvulsant drug since 1993. In addition, it has been effective in neuropathic pain,[4] diabetic neuropathy,[5] post-herpatic neuralgia,[6] and reflex sympathetic dystrophy.[7] Pre-treatment with gabapentin can block the development of hyperalgesia.[8] Studies have demonstrated that mechanical hyperalgesia surrounding the wound in post-operative patients and experimentally, heat-induced, secondary hyperalgesia share a common mechanism and that central neuronal sensitization contributes to post-operative pain.[9] Gabapentin has a selective effect on the nociceptive process involving central sensitization.[8] Gabapentin and morphine have synergistic analgesic effects in animals and in humans.[10-12] The aim of this study is to know the effect of oral gabapentin given pre-operatively on post-operative pain in patients undergoing abdominal surgeries lasting for around 2 h.

Aims

To study the effect of oral gabapentin 600 mg given 1 h prior to surgery as preemptive analgesia to attenuate post-operative pain in patients undergoing abdominal surgery under GA.

MATERIALS AND METHODS

After obtaining the approval of the Institutional Ethics Committee (Grant Medical College and Sir J J Groups of Hospitals) and written informed consent from the patients, 60 patients were included.

Inclusion criteria

Patients belonging to American Society of Anesthesiologists physical status I and II Patients undergoing elective surgery under general anesthesia Anticipated duration of surgery less than 4 h Age group between 18 and 65 years Weight range up to 20% of the ideal body weight for either sex Hemodynamic ally stable

Exclusion criteria

Patients with a history of hypertension, diabetes, and liver disease Patients with acute or chronic renal disease Patients with known neurological disease Neurosurgical and cardiovascular surgical cases Pregnant patients Patients with known psychiatric disorders Patients with anticipated difficult airway Patients on antihypertensive drugs, sedatives, hypnotics, antidepressants, and drugs with effects on the nervous system Patients already taking oral gabapentin Patients allergic to opioids and Tramadol Patients were randomly divided into two groups, with 30 patients in each group. They were randomly allocated according to computer-generated randomization. Patients in the control group received oral placebo capsules and those in the gabapentin group received 600 mg gabapentin (Neurontin 300 mg capsule; Pfizer, Mumbai, India) 1 h before surgery. The study drugs were prepared by the pharmacy and an appropriate code number was assigned. In the operating room, a crystalloid infusion was started through an IV cannula. Blood pressure (MAP), heart rate (HR), and peripheral oxygen saturation (SpO2) were monitored. For pre-medication, midazolam 0.07 mg/kg, glycopyrolate 0.004 mg/kg, and fentanyl 2µg/kg were administered intravenously on the table. After adequate pre-oxygenation for 3 min, anesthesia was induced with propofol 2 mg/kg and vecuronium 0.1 mg/kg and maintained with 60% N2O in O2 on Bain’s circuit and vecuronium 0.02 mg/kg. At the end of surgery, neuromuscular block was antagonized with neostigmine 0.05 mg/kg and glycopyrolate 0.008 mg/kg. Surgeries lasting for more than 1 h were given a repeat dose of fentanyl 1µg/kg at the end of the first hour of induction. Any increase in the HR and MAP when not settling down by deepening the plain of anesthesia was given fentanyl 0.05 µg/kg subsequently. Total duration of the surgery in both the groups and the intra-operative fentanyl in both the groups were studied. After tracheal extubation, patients were observed in the PACU for 1 h and then transferred to the surgical ward. Assessment of post-operative pain was made on the basis of the visual analog score (VAS), where 0 cm - “no pain” and 10 cm - “worst pain imaginable.” The VAS scores are taken immediately on extubation (0 h) and at 2, 4 6, 12, and 24 hours post-operatively. Post-operative analgesia was provided with Tramadol intravenously. The first dose was given in the PACU as 2 mg/kg and repeated at 8 and 16 h. If the patient still complained of pain, then rescue analgesia was given with diclofenac 75 mg slow intravenous over 10 min. The number of doses of rescue analgesia in both the groups were studied and compared. The occurrence of any side-effects, such as nausea and vomiting, respiratory depression, dizziness, somnolence, headache, and pruritus was recorded. Tramadol dose was omitted if the patient had a respiratory rate <12 breaths/min, an SpO2 measured by pulse oximetry <95%, or a serious adverse event related to opioid administration.

RESULTS

As seen in Tables 1, 2, 2a and 3, patients in both the groups are comparable in terms of demographic parameters like age, sex ratio, and weight.
Table 1

Independent t-test for equality of mean age in two study groups

GroupNMeanSDtDfP-valueSignificance
Gabapentin 600 mg3037.813.2−0.805580.424Not significant
Control3040.411.8
Table 2

Comparison of sex distribution in two study groups

GroupTreatmentMale (%)Female (%)Total
1Gabapentin 600 mg12 (40)18 (60)30
2Control12 (40)18 (60)30
Table 2a

Chi-square test for comparison of sex in the study groups

Pearson Chi-squareValuedfP-valueSignificance
0.00011.000Not significant
Table 3

Independent t-test for equality of mean weight in the two study groups

GroupNMeanSDtDfP-valueSignificance
Gabapentin 600 mg3055.08.10.421580.675Not significant
Control3054.26.5
Independent t-test for equality of mean age in two study groups Comparison of sex distribution in two study groups Chi-square test for comparison of sex in the study groups Independent t-test for equality of mean weight in the two study groups As seen from Tables 4 and 5, there is no significant difference between the groups in terms of total duration of surgery and intraoperative fentanyl usage.
Table 4

Independent t-test for equality of men duration of surgery in the two groups

GroupNMeanSDtDfP-valueSignificance
Gabapentin 600 mg30122.030.10.645580.521Not significant
Control30117.227.9
Table 5

Independent t-test (mean dose of inj. Fentanyl in µg)

GroupNMeanSDtDfP-valueSignificance
Gabapentin 600 mg30146.332.3−0.258580.798Not significant
Control30148.327.7
Independent t-test for equality of men duration of surgery in the two groups Independent t-test (mean dose of inj. Fentanyl in µg) As seen from Tables 6 and 7 and Figure 1, the VAS scores are significantly lower in the gabapentin 600 mg group as compared to placebo at 0, 2, 4, 6, 12, and 24 h of surgery.
Table 6

Independent t-test (mean VAS)

VasGroupNMeanSDtDfP-valueSignificance
VAS 0 hGabapentin 600 mg301.90.7−3.227580.002Significant
Control302.40.7
VAS 2 hGabapentin 600 mg302.30.7−3.928580.000Significant
Control303.00.7
VAS 4 hGabapentin 600 mg303.20.8−2.850580.006Significant
Control303.70.7
VAS 6 hGabapentin 600 mg302.90.7−9.050580.000Significant
Control304.40.6
VAS 12 hGabapentin 600 mg303.60.6−6.530580.000Significant
Control304.60.6
VAS 24 hGabapentin 600 mg303.70.7−5.046580.000Significant
Control304.60.6

VAS: Visual analog score

Table 7

Comparison of the VAS between the study groups (Repeated measure ANOVA)

VasGabapentin 600 mg
Control
MeanSDMeanSD
VAS 0 h1.90.72.40.7
VAS 2 h2.30.73.00.7
VAS 4 h3.20.83.70.7
VAS 6 h2.90.74.40.6
VAS 12 h3.60.64.60.6
VAS 24 h3.70.74.60.6

GroupTreatmentNSum of squaresdfFP-valueSignificance
1Gabapentin 600 mg3066.741113.20.000Significant
2Control30

VAS: Visual analog score

Figure 1

Graph comparing visual analog score in two groups

Graph comparing visual analog score in two groups Independent t-test (mean VAS) VAS: Visual analog score Comparison of the VAS between the study groups (Repeated measure ANOVA) VAS: Visual analog score As seen from Table 8, 8a and Figure 2, three patients in the gabapentin group required rescue analgesia in terms of diclofenac intravenously as compared to 13 patients in the placebo group. The three patients in the gabapentin group requiring rescue analgesia were at around 4, 7, and 12 h after surgery, respectively. Of the 13 patients requiring rescue analgesia, only one patient required it twice, at 4 and 16 h post-surgery, respectively. But, as seen, the rescue analgesia requirement in the gabapentin group was significantly lower as compared to the placebo group.
Table 8

Rescue analgesia requirement in two study groups

GroupTreatmentNo (%)Yes (%)Total
1Gabapentin 600 mg27 (90.00)3 (10.00)30
2Control17 (56.67)13 (43.33)30

Figures in parentheses are in percentage

Table 8a

Chi-square test for comparison of rescue analgesia in the study groups

Pearson chi-squareValuedfP-valueSignificance
8.52310.004Significant
Figure 2

Rescue analgesia requirement in both groups in post-operative period

Rescue analgesia requirement in both groups in post-operative period Rescue analgesia requirement in two study groups Figures in parentheses are in percentage Chi-square test for comparison of rescue analgesia in the study groups

DISCUSSION

The results of our pre-operative oral single-dose study investigating the acute post-operative analgesic effects of gabapentin in patients undergoing abdominal surgeries requiring general anesthesia show that gabapentin decreased post-operative pain scores at 0, 2, 4, 6, 12, and 24 h of surgery and decreased requirement of rescue analgesia when compared with placebo. Post-operative pain is not purely nociceptive in nature and may consist of inflammatory, neurogenic, and visceral components. Therefore, multimodal analgesic techniques utilizing a number of drugs acting on different analgesic mechanisms are becoming increasingly popular.[1] The main aim in combining different analgesic drugs is to obtain synergistic or additive analgesia, allowing a smaller dose of each drug with an improved safety profile. This can be achieved by combining analgesics acting at different locations (e.g., centrally and peripherally acting analgesics). We used Tramadol as a fixed-dose regimen for postoperative pain control and Diclofenac as rescue analgesia to be given only when the patient demanded for it. Tramadol is widely used for moderate-to-severe post-operative pain. Its efficacy is a result of two complementary mechanisms of action: stimulation of µ-opioid receptors and inhibition of norepinephrine and 5-hydroxytryptamine reuptake in pain pathways.[13] Non-steroidal anti-inflammatory drugs are commonly used analgesics for minor surgery and are useful adjunctive analgesics in patients undergoing major surgery, decreasing pain and opioid requirements. They are well established, effective, and inexpensive. However, their use may be limited by adverse renal, gastrointestinal, and hemostatic effects. Antihyperalgesic drugs such as gabapentin may have a role in post-operative pain, and the combination with other antinociceptive drugs may produce synergistic analgesia effects.[910] Significantly low VAS scores immediately after extubation, i.e. 0 h (1.9 vs. 2.4, P=0.002) in the gabapentin group may suggest the synergistic effect of gabapentin with fentanyl. Decreased rescue analgesic requirement in the gabapentin group also suggests the synergistic effect of gabapentin with Tramadol. Turan et al, in 2004, also found that 1,200 mg gabapentin given 1 h prior to surgery significantly reduced the post-operative pain scores and Tramadol requirements in Total abdominal hysterectomy patients. In animal models of nociception, gabapentin reduces the hypersensitivity associated with nerve injury, inflammation, and pain after surgery.[89] Mechanical hyperalgesia surrounding the wound in post-operative patients and experimental, heat-induced secondary hyperalgesia share a common mechanism -central neuronal sensitization, which may contribute to some aspects of post-operative pain. Antihyperalgesic drugs such as gabapentin may have a role in post-operative pain, and the combination with other antinociceptive drugs may produce synergistic analgesia effects.[910] Gabapentin enhanced the analgesic effect of morphine in healthy volunteers,[11] and the combination produced better analgesia in comparison with morphine alone in patients suffering neuropathic cancer pain.[12] Gabapentin significantly decreased morphine consumption and pain in patients after mastectomy[13] although the patients were evaluated for only 4 h after surgery. Gabapentin is well tolerated. It has few side-effects and minor interactions with other drugs when used for the treatment of chronic pain.[7] We did not observe any significant side-effects associated with a single oral dose of gabapentin. Our results are similar to other published reports.[14-17]

CONCLUSION

Preemptive use of gabapentin significantly decreases the post-operative pain and rescue analgesic requirement in patients undergoing abdominal surgery under general anesthesia.
  16 in total

1.  Gabapentin adjunctive therapy in neuropathic pain states.

Authors:  H Rosner; L Rubin; A Kestenbaum
Journal:  Clin J Pain       Date:  1996-03       Impact factor: 3.442

2.  Gabapentin provides effective postoperative analgesia whether administered pre-emptively or post-incision.

Authors:  Chandra Kant Pandey; Vinay Singhal; Mukesh Kumar; Archana Lakra; Rajeev Ranjan; Rashmi Pal; Mehdi Raza; Uttam Singh; Prabhat Kumar Singh
Journal:  Can J Anaesth       Date:  2005-10       Impact factor: 5.063

Review 3.  Neurophysiology of opioid poorly responsive pain.

Authors:  A H Dickenson
Journal:  Cancer Surv       Date:  1994

4.  Mechanisms of postoperative pain: clinical indications for a contribution of central neuronal sensitization.

Authors:  Jesper Dirks; Steen Møiniche; Karen-Lisa Hilsted; Jørgen B Dahl
Journal:  Anesthesiology       Date:  2002-12       Impact factor: 7.892

5.  Gabapentin enhances the analgesic effect of morphine in healthy volunteers.

Authors:  K Eckhardt; S Ammon; U Hofmann; A Riebe; N Gugeler; G Mikus
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

6.  The analgesic effects of gabapentin after total abdominal hysterectomy.

Authors:  Alparslan Turan; Beyhan Karamanlioğlu; Dilek Memiş; Pinar Usar; Zafer Pamukçu; Mevlüt Türe
Journal:  Anesth Analg       Date:  2004-05       Impact factor: 5.108

7.  Gabapentin for the prevention of postoperative pain after vaginal hysterectomy.

Authors:  Michael G F Rorarius; Susanna Mennander; Pentti Suominen; Sirpa Rintala; Arto Puura; Raili Pirhonen; Raili Salmelin; Maija Haanpää; Erkki Kujansuu; Arvi Yli-Hankala
Journal:  Pain       Date:  2004-07       Impact factor: 6.961

8.  Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

Authors:  M Backonja; A Beydoun; K R Edwards; S L Schwartz; V Fonseca; M Hes; L LaMoreaux; E Garofalo
Journal:  JAMA       Date:  1998-12-02       Impact factor: 56.272

9.  Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy.

Authors:  Chandra Kant Pandey; Shio Priye; Surendra Singh; Uttam Singh; Ram Badan Singh; Prabhat Kumar Singh
Journal:  Can J Anaesth       Date:  2004-04       Impact factor: 5.063

Review 10.  Efficacy of postoperative epidural analgesia: a meta-analysis.

Authors:  Brian M Block; Spencer S Liu; Andrew J Rowlingson; Anne R Cowan; John A Cowan; Christopher L Wu
Journal:  JAMA       Date:  2003-11-12       Impact factor: 56.272

View more
  6 in total

1.  Gabapentin significantly decreases posthemorrhoidectomy pain: a prospective study.

Authors:  Vitaliy Poylin; Jeanne Quinn; Kristin Messer; Deborah Nagle
Journal:  Int J Colorectal Dis       Date:  2014-10-01       Impact factor: 2.571

2.  Comparative Pre-Emptive Analgesic Efficacy Study of Novel Antiepileptic Agents Lamotrigine and Topiramate in Patients Undergoing Major Surgeries at a Tertiary Care Hospital: A Randomized Double Blind Clinical Trial.

Authors:  Ankush Gupta; Uma A Bhosale; Priyank Shah; Radha Yegnanarayan; Shalini Sardesai
Journal:  Ann Neurosci       Date:  2016-09-09

3.  Effectiveness of gabapentin as a postoperative analgesic in children undergoing appendectomy.

Authors:  Katherine J Baxter; Jennifer Hafling; Jennifer Sterner; Adarsh U Patel; Helen Giannopoulos; Kurt F Heiss; Mehul V Raval
Journal:  Pediatr Surg Int       Date:  2018-05-04       Impact factor: 1.827

4.  Effects of gabapentin on pain and opioid consumption after abdominal hysterectomy.

Authors:  Fatemeh Frouzanfard; Mohammad Reza Fazel; Azadeh Abolhasani; Esmaeil Fakharian; Golmabas Mousavi; Alireza Moravveji
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

5.  A Randomized Double-Blind Placebo-Controlled Study to Compare Preemptive Analgesic Efficacy of Novel Antiepileptic Agent Lamotrigine in Patients Undergoing Major Surgeries.

Authors:  Priyank Shah; Uma A Bhosale; Ankush Gupta; Radha Yegnanarayan; Shalini Sardesai
Journal:  N Am J Med Sci       Date:  2016-02

Review 6.  Dose-related beneficial and harmful effects of gabapentin in postoperative pain management - post hoc analyses from a systematic review with meta-analyses and trial sequential analyses.

Authors:  Maria Louise Fabritius; Jørn Wetterslev; Ole Mathiesen; Jørgen B Dahl
Journal:  J Pain Res       Date:  2017-11-01       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.